PepGen
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
245 Main St Fl 2, Cambridge, Massachuset...Phone Number
(781) 797-0979Website
www.pepgen.comRevenue
$86.5 MillionStock Symbol
PEPGIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About PepGen
Founded in 2018, PepGen clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company is based in Cambridge, Massachusetts.Explore more
PepGen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PepGen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on PepGen recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when PepGen launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if PepGen has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at PepGen
PepGen, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once PepGen has new funding data
Click to see if PepGen had a recent Job posting/layoffs
Check out if PepGen is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined PepGen as Masked Content
Find 3 more new buyers
Compare Similar Companies to PepGen
Compare insights from companies similar to PepGen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PepGen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PepGen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PepGen.
PepGen financials insights
Gather financial insights about PepGen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$45M
2021
Unspecified
$11.3M
PepGen Tech Stack
A closer look at the technologies used by PepGen
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Research & Development, Pharmaceuticals
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
PepGen News & Media
Is PepGen (PEPG) One of the Best NASDAQ Stocks Under $5 to Buy Right Now?
PepGen Inc. (NASDAQ:PEPG) is one of the best NASDAQ stocks under $5 to buy right now. On May 12, PepGen reported Q1 2026 financial results, recording a net loss of $17.8 million, or $0.26 per share, compared to a net loss of $30.2 million for Q1 2025. R&D expenses decreased to $13.0 million, down from […]INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ: PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PepGen
Sign Up For FreeTo access detailed company insights
Founded in 2018, PepGen clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company is based in Cambridge, Massachusetts.... Read More
